Evidence map›Paper›PMID 32117959›Full record

ReviewFrontiers in cell and developmental biology2020

Mitochondrial Interactome: A Focus on Antiviral Signaling Pathways.

Giulia Refolo, Tiziana Vescovo, Mauro Piacentini, Gian Maria Fimia, Fabiola Ciccosanti

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 106 citations in OpenAlex.

  1. Review
  2. Article
  3. Apolipoproteins L involvement in immunity.Journal of human immunity · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Crosstalk between vault RNAs and innate immunity.Molecular biology reports · 2024
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Giulia RefoloLazzaro Spallanzani, National Institute for Infectious Diseases - IRCCS, Rome, Italy.
Tiziana VescovoLazzaro Spallanzani, National Institute for Infectious Diseases - IRCCS, Rome, Italy.
Mauro PiacentiniLazzaro Spallanzani, National Institute for Infectious Diseases - IRCCS, Rome, Italy.
Gian Maria FimiaLazzaro Spallanzani, National Institute for Infectious Diseases - IRCCS, Rome, Italy.
Fabiola CiccosantiLazzaro Spallanzani, National Institute for Infectious Diseases - IRCCS, Rome, Italy.
Istituti di Ricovero e Cura a Carattere Scientifico · ITIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last years, proteomics has represented a valuable approach to elucidate key aspects in the regulation of type I/III interferons (IFNs) and autophagy, two main processes involved in the response to viral infection, to unveil the molecular strategies that viruses have evolved to counteract these processes. Besides their main metabolic roles, mitochondria are well recognized as pivotal organelles in controlling signaling pathways essential to restrain viral infections. In particular, a major role in antiviral defense is played by mitochondrial antiviral signaling (MAVS) protein, an adaptor protein that coordinates the activation of IFN inducing pathways and autophagy at the mitochondrial level. Here, we provide an overview of how mass spectrometry-based studies of protein-protein interactions and post-translational modifications (PTMs) have fostered our understanding of the molecular mechanisms that control the mitochondria-mediated antiviral immunity.

Indexed as

mitochondriamitochondrial antiviral signaling proteinproteomicsretinoic acid-inducible gene IRNA virus infection

Identifiers

PMID32117959
PMCPMC7033419
OpenAlexW3005619147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.